Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Indigo Acquisition Corp.Indigo Acquisition Corp. Reports $62,889 Net Loss for Quarter Ending June 30, 2025
VanEck Bitcoin ETFVanEck Bitcoin ETF Reports 31.15% Increase in Net Assets to $1.68 Billion
BARFRESH FOOD GROUP INC.Barfresh Food Group Reports 11% Revenue Growth in Q2 2025 Despite Net Loss
Dakota Gold Corp.Dakota Gold Corp. Reports $6.5 Million Net Loss in Q2 2025, Assets Increase to $127.8 Million
TENAX THERAPEUTICS, INC.Tenax Therapeutics Reports $10.8 Million Net Loss and Increased Operating Expenses in Latest 10-Q Filing
Aterian, Inc.Aterian Reports 30.5% Revenue Decline in Q2 2025, Net Loss of $8.8 Million
Marpai, Inc.Marpai, Inc. Reports 35.2% Revenue Decline in Q2 2025, Improves Operating Loss
Bluerock Homes Trust, Inc.Bluerock Homes Trust Reports 34.3% Revenue Growth in Q2 2025 Despite Increased Expenses
Jade Biosciences, Inc.Jade Biosciences Reports $32.1 Million Net Loss in Latest Quarter, Focuses on R&D for Autoimmune Therapies
Verde Clean Fuels, Inc.Verde Clean Fuels Reports $2.55 Million Net Loss, Total Assets Rise to $68.73 Million
QUICKLOGIC CorpQuickLogic Reports 10% Revenue Decline in Q2 2025, Restructures Business Operations
FGI Industries Ltd.FGI Industries Reports 5.5% Revenue Growth but Faces Increased Net Loss in Q2 2025
Vulcan Infrastructure & Power Inc.Greenidge Generation Reports $12.9 Million Revenue with Net Loss of $4.1 Million for Q2 2025
ADIAL PHARMACEUTICALS, INC.Adial Pharmaceuticals Reports Decreased Net Loss and Increased Cash Reserves for Q2 2025
SurgePays, Inc.SurgePays Reports 23.7% Revenue Decline in Q2 2025 Amid Funding Cessation
AXT INCAXT, Inc. Reports 35.6% Revenue Decline in Q2 2025 Amid Export Restrictions
Enliven Therapeutics, Inc.Enliven Therapeutics Reports $25.3 Million Net Loss in Q2 2025, Increases R&D Spending
Yubo International Biotech LtdYubo International Biotech Reports Decreased Net Loss and No Revenue in Q2 2025
Acrivon Therapeutics, Inc.Acrivon Therapeutics Reports $21M Net Loss in Q2 2025, Focuses on Oncology Pipeline
Roadzen Inc.Roadzen Inc. Reports 22% Revenue Growth and Significant Cost Reductions for Q2 2025
MARCHEX INCMarchex Reports 3% Revenue Decline in Q2 2025, Achieves Net Income of $85,000
WESTWATER RESOURCES, INC.Westwater Resources Reports $3.9 Million Net Loss for Q2 2025, Progress on Kellyton Graphite Plant
Silo Pharma, Inc.Silo Pharma Reports $1.2 Million Net Loss in Q2 2025, Revenue Stable at $18,025
Performance Food Group CoPerformance Food Group Reports 8.6% Revenue Growth to $63.3 Billion for Fiscal Year Ending June 2025
DYADIC INTERNATIONAL INCDyadic International Reports Revenue Growth to $966,630 in Q2 2025, Plans Rebranding